|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 401 to 500 out of 525 for Smad7

0.033s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Interaction Experiment
Description: Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.
Interaction Experiment
Description: Cbl-b mediates TGF sensitivity by downregulating inhibitory SMAD7 in primary T cells.
Interaction Experiment
Description: Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Interaction Experiment
Description: Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors.
Interaction Experiment
Description: Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2.
Allele
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 4, Thomas Braun
Allele Type: Targeted
Attribute String: Inserted expressed sequence
Protein
Organism: Mus musculus/domesticus
Length: 426  
Fragment?: false
Publication
First Author: Kitamura K
Year: 2000
Journal: Blood
Title: Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.
Volume: 95
Issue: 11
Pages: 3371-9
Publication
First Author: Ferrigno O
Year: 2002
Journal: Oncogene
Title: Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Volume: 21
Issue: 32
Pages: 4879-84
Publication
First Author: Fukasawa H
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
Volume: 101
Issue: 23
Pages: 8687-92
Publication
First Author: Kamiya Y
Year: 2010
Journal: J Biol Chem
Title: Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.
Volume: 285
Issue: 40
Pages: 30804-13
Publication
First Author: Gruber T
Year: 2013
Journal: J Mol Cell Biol
Title: Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells.
Volume: 5
Issue: 6
Pages: 358-68
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Protein
Organism: Mus musculus/domesticus
Length: 425  
Fragment?: false
Publication
First Author: Souchelnytskyi S
Year: 1998
Journal: J Biol Chem
Title: Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors.
Volume: 273
Issue: 39
Pages: 25364-70
Publication
First Author: Hong S
Year: 2007
Journal: Nat Immunol
Title: Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2.
Volume: 8
Issue: 5
Pages: 504-13
Allele
Name: transgene insertion 1, Simon J Conway
Allele Type: Transgenic
Attribute String: Recombinase
Allele
Name: Regulatory region 54; endonuclease-mediated mutation 1, Axel Visel
Allele Type: Endonuclease-mediated
Attribute String: Modified regulatory region
Publication
First Author: Pulaski L
Year: 2001
Journal: J Biol Chem
Title: Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
Volume: 276
Issue: 17
Pages: 14344-9
Allele  
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 5.1, Mark A Magnussen
Allele Type: Targeted
Allele  
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 6.1, Mark A Magnussen
Allele Type: Targeted
Strain
Attribute String: mutant strain, coisogenic, endonuclease-mediated mutation
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Genotype
Symbol: Rr54/Rr54
Background: FVB-Rr54
Zygosity: hm
Has Mutant Allele: true
Publication
First Author: Wang L
Year: 2021
Journal: Circulation
Title: BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
Volume: 143
Issue: 14
Pages: 1394-1410
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Smad7-cre)1Sjc/?
Background: involves: 129S/Sv * C3HeB/FeJ
Zygosity: cn
Has Mutant Allele: true
HT Experiment
Series Id: GSE40510
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Smad7-cre)1Sjc/?
Background: involves: 129S4/SvJaeSor * C3HeB/FeJ
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Smad7-cre)1Sjc/?
Background: involves: 129S/Sv * 129S4/SvJaeSor * C3HeB/FeJ
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Bai Y
Year: 2004
Journal: Mol Cell
Title: Itch E3 ligase-mediated regulation of TGF-beta signaling by modulating smad2 phosphorylation.
Volume: 15
Issue: 5
Pages: 825-31
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor Tg(Smad7-cre)1Sjc/?
Background: involves: 129S/Sv * 129S4/SvJaeSor * C3HeB/FeJ
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Lee YS
Year: 2008
Journal: Biochem Biophys Res Commun
Title: AIMP1/p43 downregulates TGF-beta signaling via stabilization of smurf2.
Volume: 371
Issue: 3
Pages: 395-400
Publication
First Author: Vijayachandra K
Year: 2009
Journal: Mol Carcinog
Title: Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Volume: 48
Issue: 3
Pages: 181-186
Publication
First Author: Halder LD
Year: 2020
Journal: Nat Commun
Title: Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesicles.
Volume: 11
Issue: 1
Pages: 2331
Publication    
First Author: Li M
Year: 2020
Journal: Elife
Title: GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation.
Volume: 9
Publication
First Author: Dominitzki S
Year: 2007
Journal: J Immunol
Title: Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
Volume: 179
Issue: 4
Pages: 2041-5
Publication    
First Author: Schlereth K
Year: 2018
Journal: Elife
Title: The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium.
Volume: 7
Publication
First Author: Hohenstein P
Year: 2003
Journal: Genes Chromosomes Cancer
Title: Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
Volume: 36
Issue: 3
Pages: 273-82
Publication
First Author: Zhong X
Year: 2013
Journal: Diabetologia
Title: miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.
Volume: 56
Issue: 3
Pages: 663-74
Publication
First Author: Dong L
Year: 2021
Journal: J Cell Mol Med
Title: Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice.
Volume: 25
Issue: 10
Pages: 4860-4869
Publication
First Author: Reardon C
Year: 2008
Journal: J Immunol
Title: Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
Volume: 180
Issue: 12
Pages: 8316-26
Publication
First Author: Ito Y
Year: 2002
Journal: Dev Dyn
Title: Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.
Volume: 224
Issue: 1
Pages: 69-78
Publication
First Author: Cho C
Year: 2020
Journal: Oncogene
Title: Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis.
Volume: 39
Issue: 38
Pages: 6129-6137
Publication
First Author: Huang X
Year: 2018
Journal: Arterioscler Thromb Vasc Biol
Title: MicroRNA-21 Knockout Exacerbates Angiotensin II-Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β-SMAD3 Signaling.
Volume: 38
Issue: 5
Pages: 1086-1101
Publication
First Author: Liu Z
Year: 2012
Journal: Am J Physiol Renal Physiol
Title: Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Volume: 302
Issue: 8
Pages: F986-97
Publication
First Author: El-Gohary Y
Year: 2014
Journal: Diabetes
Title: A smad signaling network regulates islet cell proliferation.
Volume: 63
Issue: 1
Pages: 224-36
Publication
First Author: Zhang XY
Year: 2013
Journal: PLoS One
Title: Induction of thoracic aortic remodeling by endothelial-specific deletion of microRNA-21 in mice.
Volume: 8
Issue: 3
Pages: e59002
Publication
First Author: Wu J
Year: 2016
Journal: Oncogene
Title: Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
Volume: 35
Issue: 42
Pages: 5468-5479
Publication
First Author: Sakata-Goto T
Year: 2012
Journal: Bone
Title: Id2 controls chondrogenesis acting downstream of BMP signaling during maxillary morphogenesis.
Volume: 50
Issue: 1
Pages: 69-78
Publication
First Author: Pallangyo CK
Year: 2015
Journal: J Exp Med
Title: IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.
Volume: 212
Issue: 13
Pages: 2253-66
Publication
First Author: Li Y
Year: 2024
Journal: FASEB J
Title: Vascular smooth muscle cell-specific miRNA-214 deficiency alleviates simulated microgravity-induced vascular remodeling.
Volume: 38
Issue: 1
Pages: e23369
Publication
First Author: Xylourgidis N
Year: 2019
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis.
Volume: 317
Issue: 5
Pages: L678-L689
Publication
First Author: Ishida Y
Year: 2006
Journal: J Immunol
Title: Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway.
Volume: 176
Issue: 9
Pages: 5598-606
Publication
First Author: Giroux M
Year: 2010
Journal: J Immunol
Title: T cell activation leads to protein kinase C theta-dependent inhibition of TGF-beta signaling.
Volume: 185
Issue: 3
Pages: 1568-76
Publication
First Author: Tang YJ
Year: 2014
Journal: Am J Respir Cell Mol Biol
Title: Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
Volume: 51
Issue: 6
Pages: 761-71
Publication
First Author: Huang XR
Year: 2008
Journal: J Am Soc Nephrol
Title: Latent TGF-beta1 protects against crescentic glomerulonephritis.
Volume: 19
Issue: 2
Pages: 233-42
Publication
First Author: Gai Z
Year: 2010
Journal: J Am Soc Nephrol
Title: Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression.
Volume: 21
Issue: 9
Pages: 1468-76
Publication
First Author: Stavropoulos A
Year: 2022
Journal: Sci Signal
Title: Coordinated activation of TGF-β and BMP pathways promotes autophagy and limits liver injury after acetaminophen intoxication.
Volume: 15
Issue: 740
Pages: eabn4395
Publication  
First Author: Gencer S
Year: 2017
Journal: Sci Signal
Title: TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis.
Volume: 10
Issue: 502
Publication  
First Author: Sun Q
Year: 2018
Journal: J Cell Sci
Title: The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis.
Volume: 131
Issue: 6
Publication
First Author: Almahariq M
Year: 2015
Journal: Biochem J
Title: Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression.
Volume: 465
Issue: 2
Pages: 295-303
Publication
First Author: Wang Y
Year: 2020
Journal: FASEB J
Title: 8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2/3 and interacting with Smad7.
Volume: 34
Issue: 10
Pages: 13461-13473
Publication
First Author: Seitz R
Year: 2018
Journal: Invest Ophthalmol Vis Sci
Title: Cross-Inhibition of Norrin and TGF-β Signaling Modulates Development of Retinal and Choroidal Vasculature.
Volume: 59
Issue: 6
Pages: 2240-2251
Publication
First Author: Wu RS
Year: 2017
Journal: Oncotarget
Title: OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
Volume: 8
Issue: 24
Pages: 39401-39416
Publication
First Author: He W
Year: 2001
Journal: Oncogene
Title: Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis.
Volume: 20
Issue: 4
Pages: 471-83
Publication
First Author: Guda K
Year: 2001
Journal: Mol Carcinog
Title: Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
Volume: 31
Issue: 4
Pages: 204-13
Publication
First Author: Yanagi Y
Year: 1999
Journal: J Biol Chem
Title: Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins.
Volume: 274
Issue: 19
Pages: 12971-4
Publication
First Author: Yu Z
Year: 2006
Journal: Biochem Biophys Res Commun
Title: All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Volume: 340
Issue: 3
Pages: 929-34
Publication
First Author: Saika S
Year: 2006
Journal: Am J Pathol
Title: Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing.
Volume: 168
Issue: 6
Pages: 1848-60
Publication
First Author: Jeon SH
Year: 2007
Journal: J Leukoc Biol
Title: Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis.
Volume: 81
Issue: 2
Pages: 557-66
Publication
First Author: Chang X
Year: 2007
Journal: Mol Cell Biol
Title: Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor.
Volume: 27
Issue: 17
Pages: 6127-39
Publication
First Author: Kim HA
Year: 2008
Journal: J Leukoc Biol
Title: TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways.
Volume: 83
Issue: 6
Pages: 1431-9
Publication
First Author: Singh R
Year: 2009
Journal: Endocrinology
Title: Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.
Volume: 150
Issue: 3
Pages: 1259-68
Publication
First Author: Seong HA
Year: 2010
Journal: J Biol Chem
Title: Murine protein serine/threonine kinase 38 stimulates TGF-beta signaling in a kinase-dependent manner via direct phosphorylation of Smad proteins.
Volume: 285
Issue: 40
Pages: 30959-70
Publication
First Author: Ortiz C
Year: 2012
Journal: J Biol Chem
Title: Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes.
Volume: 287
Issue: 19
Pages: 15263-74
Publication
First Author: Taylor-Weiner H
Year: 2015
Journal: J Cell Sci
Title: Traction forces mediated by integrin signaling are necessary for definitive endoderm specification.
Volume: 128
Issue: 10
Pages: 1961-8
Publication
First Author: Li X
Year: 2017
Journal: Biochem Biophys Res Commun
Title: MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway.
Volume: 493
Issue: 2
Pages: 928-933
Publication
First Author: Wang R
Year: 2018
Journal: FASEB J
Title: Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells.
Volume: 32
Issue: 7
Pages: 3936-3945
Publication
First Author: Liu X
Year: 2019
Journal: Biochem Biophys Res Commun
Title: IFNγ inhibits fibroblast-leading tumor cell invasion through downregulating N-cadherin.
Volume: 512
Issue: 3
Pages: 544-551
Publication
First Author: Bos JM
Year: 2012
Journal: J Cell Biochem
Title: TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy.
Volume: 113
Issue: 6
Pages: 1896-903
Publication  
First Author: Igalouzene R
Year: 2022
Journal: J Clin Invest
Title: SMAD4 TGF-β-independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation.
Volume: 132
Issue: 8
Protein Domain
Type: Homologous_superfamily
Description: Smad proteins are signal transducers and transcriptional comodulators of the TGF-beta superfamily of ligands, which play a central role in regulating a broad range of cellular responses, including cell growth, differentiation, and specification of developmental fate, in diverse organisms from Caenorhabditis elegans to humans. Ligand binding to specific transmembrane receptor kinases induces receptor oligomerisation and phosphorylation of the receptor specific Smad protein (R-Smad) in the cytoplasm. The R-Smad proteins regulate distinct signalling pathways. Smad1, 5 and 8 mediate the signals of bone morphogenetic proteins (BMPs), while Smad2 and 3 mediate the signals of activins and TGF-betas. Upon ligand stimulation, R-Smad proteins are phosphorylated at the conserved C-terminal tail sequence, SS*xS* (where S* denotes a site of phosphorylation). The phosphorylated states of R-Smad proteins form heteromeric complexes with Smad4 and are translocated into the nucleus. In the nucleus, the heteromeric complexes function as gene-specific transcription activators by binding to promoters and interacting with transcriptional coactivators. Smad6 and Smad7 are inhibitory Smad proteins that inhibit TGF-beta signalling by interfering with either receptor-mediated phosphorylation or hetero-oligomerisation between Smad4 and R-Smad proteins. Smad proteins comprise two conserved MAD homology domains, one in the N terminus (MH1) and one in the C terminus (MH2), separated by a more variable, proline-rich linker region. The MH1 domain has a role in DNA binding and negatively regulates the functions of MH2 domain, whereas the MH2 domain is responsible for transactivation and mediates phosphorylation-triggered heteromeric assembly between Smad4 and R-Smad [, ]. The MH1 domain adopts a compact globular fold, with four alpha helices, six short beta strands, and five loops. The N-terminal half of the sequence consists of three alpha helices, and the C-terminal half contains all six beta strands, which form two small beta sheets and one beta hairpin. The fourth alpha helix is located in the hydrophobic core of the molecule, surrounded by the N-terminal three alpha helices on one side and by the two small beta sheets and the beta hairpin on the other side. These secondary structural elements are connected with five intervening surface loops. The MH1 domain employs a novel DNA-binding motif, an 11-residue β-hairpin formed by strands B2 and B3, to contact DNA in the major groove. Two residues in the L3 loop and immediately preceding strand B2 also contribute significantly to DNA recognition. The beta hairpin appears to protrude outward from the globular MH1 core [].
Protein Domain
Type: Domain
Description: Smad proteins are signal transducers and transcriptional comodulators of the TGF-beta superfamily of ligands, which play a central role in regulating a broad range of cellular responses, including cell growth, differentiation, and specification of developmental fate, in diverse organisms from Caenorhabditis elegans to humans. Ligand binding to specific transmembrane receptor kinases induces receptor oligomerisation and phosphorylation of the receptor specific Smad protein (R-Smad) in the cytoplasm. The R-Smad proteins regulate distinct signalling pathways. Smad1, 5 and 8 mediate the signals of bone morphogenetic proteins (BMPs), while Smad2 and 3 mediate the signals of activins and TGF-betas. Upon ligand stimulation, R-Smad proteins are phosphorylated at the conserved C-terminal tail sequence, SS*xS* (where S* denotes a site of phosphorylation). The phosphorylated states of R-Smad proteins form heteromeric complexes with Smad4 and are translocated into the nucleus. In the nucleus, the heteromeric complexes function as gene-specific transcription activators by binding to promoters and interacting with transcriptional coactivators. Smad6 and Smad7 are inhibitory Smad proteins that inhibit TGF-beta signalling by interfering with either receptor-mediated phosphorylation or hetero-oligomerisation between Smad4 and R-Smad proteins. Smad proteins comprise two conserved MAD homology domains, one in the N terminus (MH1) and one in the C terminus (MH2), separated by a more variable, proline-rich linker region. The MH1 domain has a role in DNA binding and negatively regulates the functions of MH2 domain, whereas the MH2 domain is responsible for transactivation and mediates phosphorylation-triggered heteromeric assembly between Smad4 and R-Smad [, ]. The MH1 domain adopts a compact globular fold, with four alpha helices, six short beta strands, and five loops. The N-terminal half of the sequence consists of three alpha helices, and the C-terminal half contains all six beta strands, which form two small beta sheets and one beta hairpin. The fourth alpha helix is located in the hydrophobic core of the molecule, surrounded by the N-terminal three alpha helices on one side and by the two small beta sheets and the beta hairpin on the other side. These secondary structural elements are connected with five intervening surface loops. The MH1 domain employs a novel DNA-binding motif, an 11-residue β-hairpin formed by strands B2 and B3, to contact DNA in the major groove. Two residues in the L3 loop and immediately preceding strand B2 also contribute significantly to DNA recognition. The beta hairpin appears to protrude outward from the globular MH1 core [].
Publication
First Author: Shi Y
Year: 1998
Journal: Cell
Title: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling.
Volume: 94
Issue: 5
Pages: 585-94
Publication
First Author: Iezaki T
Year: 2016
Journal: J Bone Miner Res
Title: The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Volume: 31
Issue: 3
Pages: 573-84
Publication
First Author: Chung JY
Year: 2022
Journal: Int J Biol Sci
Title: AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice.
Volume: 18
Issue: 14
Pages: 5489-5502
Publication
First Author: Latella G
Year: 2009
Journal: Eur J Clin Invest
Title: Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
Volume: 39
Issue: 2
Pages: 145-56
Publication
First Author: Latella G
Year: 2009
Journal: Liver Int
Title: Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Volume: 29
Issue: 7
Pages: 997-1009
Publication
First Author: Li Y
Year: 2021
Journal: FASEB J
Title: Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
Volume: 35
Issue: 11
Pages: e21947
Publication
First Author: Su BH
Year: 2016
Journal: J Pathol
Title: Over-expression of prothymosin-α antagonizes TGFβ signalling to promote the development of emphysema.
Volume: 238
Issue: 3
Pages: 412-22
Publication
First Author: Shen R
Year: 2006
Journal: J Biol Chem
Title: Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.
Volume: 281
Issue: 6
Pages: 3569-76
Publication
First Author: Gu W
Year: 2015
Journal: PLoS Biol
Title: A novel TGFβ modulator that uncouples R-Smad/I-Smad-mediated negative feedback from R-Smad/ligand-driven positive feedback.
Volume: 13
Issue: 2
Pages: e1002051
Publication  
First Author: Yamamoto N
Year: 2016
Journal: Mol Cell Endocrinol
Title: Heat shock protein 22 (HSPB8) limits TGF-β-stimulated migration of osteoblasts.
Volume: 436
Pages: 1-9
Protein
Organism: Mus musculus/domesticus
Length: 244  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 235  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 179  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 143  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 209  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 194  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 204  
Fragment?: true